Prevalence of gastric precancerous lesions among chronic dyspeptic patients and related common risk factors

European Journal of Cancer Prevention

Volumn 24, Issue 5, 2015, Pages 400-406

  Ajdarkosh, Hossein ^a   Sohrabi, Masoudreza ^a   Moradniani, Mosayeb ^a   Rakhshani, Naser ^a   Sotodeh, Masoud ^b   Hemmasi, Gholamreza ^a   Khoonsari, Mahmood ^a   Ameli, Mitra ^a   Malekzadeh, Reza ^b   Zamani, Farhad ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

dyspepsia; gastric atrophy; gastric cancer; Helicobacter pylori; intestinal metaplasia

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CHRONIC DYSPEPSIA; CLINICAL PROTOCOL; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE BLIND PROCEDURE; DYSPEPSIA; DYSPLASIA; FEMALE; GASTRIC DYSPLASIA; GASTRIC PRECANCEROUS LESION; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTERMEDIATE RISK PATIENT; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGIST; PATHOPHYSIOLOGY; PRECANCER; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; STOMACH ATROPHY; STOMACH BIOPSY; STOMACH CANCER; STOMACH DISEASE; CANCER STAGING; CHRONIC DISEASE; COMPLICATION; FOLLOW UP; HELICOBACTER PYLORI; IRAN; MICROBIOLOGY; PRECANCEROUS CONDITIONS; PREGNANCY; PROGNOSIS; STOMACH NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PREGNANCY; PREVALENCE; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84938797934     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000118     Document Type: Article

References (41)

1. Adamu MA, Weck MN, Rothenbacher D, Brenner H (2011). Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer 128:1652-1658.
2. Alborzi A, Soltani J, Pourabbas B, Oboodi B, Haghighat M, Hayati M, Rashidi M (2006). Prevalence of Helicobacter pylori infection in children (south of Iran). Diagn Microbiol Infect Dis 54:259261.
3. Diagn Microbiol Infect Dis 54:259-261. Asaka M (2012). Elimination of gastric cancer from Japan. Nihon Rinsho 70:1667-1672.
4. Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, Mousavi SM, et al. (2010). Gastric cancer in Ardabil, Iran - a review and update on cancer registry data. Asian Pac J Cancer Prev 11:595-599.
5. Bonequi P, Meneses-Gonzlez F, Correa P, Rabkin CS, Camargo MC (2013). Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control 24:217-231.
6. Coleman HG, Bhat S, Johnston BT, McManus D, Gavin AT, Murray LJ (2012). Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barretts esophagus. Gastroenterology 142:233-240.
7. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. (1990). Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 50:4737-4740.
8. Courillon-Mallet A (2014). Follow-up of patients after Helicobacter pylori eradication. Rev Prat 64:211-214.
9. Dixon MF, Genta RM, Yardley JH, Correa P (1996). Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161-1181.
10. Dixon MF, Genta RM, Yardley JH, Correa P (1997). Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter Suppl 1 (Suppl 1):S17-S24.
11. El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY (2001). Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 54:679-683.
12. Eriksson NK, Kárkkáinen PA, Fárkkilá MA, Arkkila PE (2008). Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis 40:355-360.
13. Eshmuratov A, Nah JC, Kim N, Lee HS, Lee HE, Lee BH, et al. (2010). The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci 55:1364-1375.
14. Felley C, Bouzourene H, VanMelle MB, Hadengue A, Michetti P, Dorta G, et al. (2012). Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia. World J Gastroenterol 18:2076-2083.
15. Hossein Somi M, Mirinezhad K, Farhang S, Jazayeri E, Sani A, Seif-Farshadi M, et al. (2006). Gastrointestinal cancer occurrence in East Azarbaijan: a five year study from North Western Iran. Asian Pac J Cancer Prev 7:309-312.
16. Islami F, Kamangar F (2008). Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 1:329-338.
17. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61:69-90.
18. Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, et al. (2013). Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver 7:303-310.
19. Kim J, Cho YA, Choi WJ, Jeong SH (2014). Gene-diet interactions in gastric cancer risk: a systematic review. World J Gastroenterol 20:9600-9610.
20. Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Lee SH, et al. (2013). Long-term followup of Helicobacter pylori reinfection rate and its associated factors in Korea. Helicobacter 18:135-142.
21. Kim N, Park YS, Cho SI, Lee HS, Choe G, Kim IW, et al. (2008). Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 13:245-255.
22. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med 13:143-146.
23. Leung WK, Ng EK, Chan WY, Auyeung AC, Chan KF, Lam CC, et al. (2005). Risk factors associated with the development of intestinal metaplasia in firstdegree relatives of gastric cancer patients. Cancer Epidemiol Biomarkers Prev 14:2982-2986.
24. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol 57:37-42.
25. Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 12:576-583.
26. Mansour-Ghanaei F, Joukar F, Baghaei SM, Yousefi-Mashhoor M, Naghipour MR, Sanaei O, et al. (2012a). Gastric precancerous lesions in first degree relatives of patients with known gastric cancer: a cross-sectional prospective study in Guilan Province, north of Iran. Asian Pac J Cancer Prev 13:1779-1782.
27. Mansour-Ghanaei F, Sokhanvar H, Joukar F, Shafaghi A, Yousefi-Mashhour M, Valeshabad AK, et al. (2012b). Endoscopic findings in a mass screening program for gastric cancer in a high risk region - Guilan province of Iran. Asian Pac J Cancer Prev 13:1407-1412.
28. Mansour-Ghanaei F, Joukar F, Soati F, Mansour-Ghanaei A, Atrkar-Roushan Z (2013). Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran. Asian Pac J Cancer Prev 14:3549-3554.
29. Mohebbi M, Mahmoodi M, Wolfe R, Nourijelyani K, Mohammad K, Zeraati H, Fotouhi A (2008). Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer 8:137.
30. Muller LB, Fagundes RB, Moraes CC, Rampazzo A (2007). Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia. Arq Gastroenterol 44:93-98.
31. Pan KF, Formichella L, Zhang L, Zhang Y, Ma JL, Li ZX, et al. (2014). Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population. Int J Cancer 134:2118-2125.
32. Rizzato C, Kato I, Plummer M, Muñoz N, Stein A, Jan van Doorn L, et al. (2013). Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer 133:315-322.
33. Rugge M, Farinati F, Baffa R, Sonego F, Di Mario F, Leandro G, Valiante F (1994). Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology 107:1288-1296.
34. Sehdev A, Catenacci DV (2013). Gastroesophageal cancer: focus on epidemiology, classification, and staging. Discov Med 16:103-111.
35. Shin WG, Kim HU, Song HJ, Hong SJ, Shim KN, Sung IK, Kim JG, Korean College of Helicobacter and Upper Gastrointestinal Research (2012). Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer. Dig Dis Sci 57:746-752.
36. Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, et al. (2011). Predictors for neoplastic progression in patients with Barretts esophagus: a prospective cohort study. Am J Gastroenterol 106: 1231-1238.
37. Vannella L, Lahner E, Annibale B (2012). Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol 18:1279-1285.
38. Yako-Suketomo H, Katanoda K (2009). Comparison of time trends in stomach cancer mortality (1990-2006) in the world, from theWHO mortality database. Jpn J Clin Oncol 39:622-623.
39. Yavari P, Sadrolhefazi B, Mohagheghi MA, Madani H, Mosavizadeh A, Nahvijou A, et al. (2008). An epidemiological analysis of cancer data in an Iranian hospital during the last three decades. Asian Pac J Cancer Prev 9:145-150.
40. You WC, Li JY, Blot WJ, Chang YS, Jin ML, Gail MH, et al. (1999). Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 83:615-619.
41. Zhang Q, Lian Z, Wang L, Wang Y, Zhi F, An S, et al. (2012). Analysis of alarming signals for the progression of atrophic gastritis to dysplasia. Rev Esp Enferm Dig 104:399-404.